Enlivex Therapeutics Ltd. Quarterly Liabilities, Current in USD from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Enlivex Therapeutics Ltd. quarterly Liabilities, Current history and growth rate from Q4 2013 to Q2 2024.
  • Enlivex Therapeutics Ltd. Liabilities, Current for the quarter ending June 30, 2024 was $2.84M, a 43.1% decline year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.84M -$2.15M -43.1% Jun 30, 2024 6-K 2024-08-30
Q4 2023 $6.06M -$546K -8.26% Dec 31, 2023 6-K 2024-08-30
Q2 2023 $4.99M +$778K +18.5% Jun 30, 2023 6-K 2023-09-01
Q4 2022 $6.61M +$1.89M +40% Dec 31, 2022 20-F 2024-04-30
Q2 2022 $4.21M -$363K -7.93% Jun 30, 2022 6-K 2022-08-22
Q4 2021 $4.72M +$346K +7.91% Dec 31, 2021 20-F 2023-04-10
Q2 2021 $4.58M -$433K -8.64% Jun 30, 2021 6-K 2021-08-06
Q4 2020 $4.37M -$1.61M -26.9% Dec 31, 2020 20-F 2022-04-29
Q2 2020 $5.01M Jun 30, 2020 6-K/A 2020-10-13
Q4 2019 $5.98M +$4.85M +429% Dec 31, 2019 20-F 2021-04-30
Q4 2018 $1.13M +$670K +146% Dec 31, 2018 20-F 2020-04-30
Q4 2017 $460K -$1.47M -76.2% Dec 31, 2017 20-F/A 2020-01-23
Q4 2016 $1.93M -$583K -23.2% Dec 31, 2016 20-F 2018-04-23
Q4 2015 $2.51M +$234K +10.3% Dec 31, 2015 20-F 2017-02-24
Q4 2014 $2.28M +$2.15M +1640% Dec 31, 2014 20-F 2016-03-29
Q4 2013 $131K Dec 31, 2013 20-F 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.